- Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–1 cdc.gov
- Here’s how kids’ COVID vaccines are holding up in the real world amid omicron Ars Technica
- What’s Holding Up the COVID Vaccines for Children Under 5? ProPublica
- Third vaccine dose boosts Omicron protection, with some waning CIDRAP
- Study: Pfizer COVID-19 vaccine did not protect younger children well from Omicron FOX 26 Houston
- View Full Coverage on Google News
Source: Google Finance – Market News